Invention Grant
- Patent Title: Notochordal cell matrix as a stimulant for intervertebral disc regeneration
-
Application No.: US16068752Application Date: 2017-01-10
-
Publication No.: US11607473B2Publication Date: 2023-03-21
- Inventor: Keita Ito , Stefan Antonius Henricus de Vries
- Applicant: Technische Universiteit Eindhoven
- Applicant Address: NL Eindhoven
- Assignee: Technische Universiteit Eindhoven
- Current Assignee: Technische Universiteit Eindhoven
- Current Assignee Address: NL Eindhoven
- Agency: Oliff PLC
- International Application: PCT/EP2017/050431 WO 20170110
- International Announcement: WO2017/121736 WO 20170720
- Main IPC: A61L27/36
- IPC: A61L27/36 ; A61K9/00 ; A61K35/12 ; A61K35/30

Abstract:
A solubilized notochordal cell matrix powder dissolved in a carrier solvent or formed as a gel is provided. The notochordal cell matrix powder originates from lyophilized and treated porcine nucleus pulposus tissue containing notochordal cells. The powder contains less than 20% of porcine nucleid acids, and the powder contains a substantially unchanged amount of porcine protein content compared to the originating porcine nucleus pulposus tissue. The solubilized notochordal cell matrix powder is capable of stimulating native or stem cells to proliferate and produce a significant increase inglycosaminoglycansand type-II collagen matrix. Embodiments of the invention can be used for the disc regenerative treatment of discogenic back and neck pain in an orthopaedic and/or pharmaceutical setting/approach.
Public/Granted literature
- US20190022278A1 Notochordal Cell Matrix as a Stimulant for Intervertebral Disc Regeneration Public/Granted day:2019-01-24
Information query